Yubo International Biotech (YBGJ) Short Interest Ratio & Short Volume → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free YBGJ Stock Alerts $0.49 -0.08 (-14.04%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Yubo International Biotech Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume1,100 sharesChange Vs. Previous Month-90.91%Dollar Volume Sold Short$95.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares118,180,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume1,100 sharesAverage Trading Volume80,685 sharesToday's Volume Vs. Average1% Short Selling Yubo International Biotech ? Sign up to receive the latest short interest report for Yubo International Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatYBGJ Short Interest Over TimeYBGJ Days to Cover Over TimeYBGJ Percentage of Float Shorted Over Time Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. Yubo International Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024100 shares $95.00 -90.9%N/A0.2 $0.95 3/31/20241,100 shares $1,089.00 +450.0%N/A0.1 $0.99 3/15/2024200 shares $65.00 No ChangeN/A1 $0.33 2/29/2024200 shares $103.60 +100.0%N/A2 $0.52 2/15/2024100 shares $30.00 No ChangeN/A0 $0.30 1/15/2024100 shares $30.00 No ChangeN/A1 $0.30 Get the Latest News and Ratings for YBGJ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Yubo International Biotech and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023100 shares $30.00 No ChangeN/A0.3 $0.30 12/15/2023100 shares $52.00 No ChangeN/A1 $0.52 11/30/2023100 shares $51.53 No ChangeN/A1 $0.52 8/15/2023100 shares $54.50 -96.9%N/A0 $0.55 7/31/20233,200 shares $1,087.68 No ChangeN/A32 $0.34 7/15/20233,200 shares $1,087.68 No ChangeN/A1.8 $0.34 6/15/2023100 shares $8.50 No ChangeN/A0.1 $0.09 2/28/20235,000 shares $437.50 No ChangeN/A50 $0.09 2/15/20235,000 shares $440.00 No ChangeN/A50 $0.09 1/31/20235,000 shares $475.00 No ChangeN/A50 $0.10 1/15/20235,000 shares $475.00 No ChangeN/A50 $0.10 12/30/20225,000 shares $475.00 No ChangeN/A6.3 $0.10 12/15/20225,000 shares $410.00 No ChangeN/A0.4 $0.08 11/30/20225,000 shares $634.50 No ChangeN/A12.5 $0.13 11/15/20225,000 shares $698.00 No ChangeN/A0 $0.14 10/31/20225,000 shares $698.00 No ChangeN/A50 $0.14 10/15/20225,000 shares $698.00 No ChangeN/A50 $0.14 9/30/20225,000 shares $698.00 No ChangeN/A0.7 $0.14 9/15/20225,000 shares $550.00 -38.3%N/A0.1 $0.11 8/31/20228,100 shares $958.03 -17.4%N/A20.3 $0.12 8/15/20229,800 shares $980.00 +96.0%N/A0.7 $0.10 7/31/20225,000 shares $500.00 No ChangeN/A1.4 $0.10 7/15/20225,000 shares $650.00 No ChangeN/A50 $0.13 6/30/20225,000 shares $747.50 No ChangeN/A50 $0.15 6/15/20225,000 shares $987.50 No ChangeN/A8.3 $0.20 5/31/20225,000 shares $350.00 No ChangeN/A0.3 $0.07 5/15/20225,000 shares $700.00 No ChangeN/A5 $0.14 4/30/20225,000 shares $612.75 No ChangeN/A1.3 $0.12 4/15/20225,000 shares $750.00 -41.9%N/A0.3 $0.15 3/31/20228,600 shares $2,147.42 No ChangeN/A86 $0.25 3/15/20228,600 shares $2,504.75 No ChangeN/A86 $0.29 2/28/20228,600 shares $2,504.75 No ChangeN/A0 $0.29 2/15/20228,600 shares $2,504.75 No ChangeN/A86 $0.29 1/31/20228,600 shares $2,524.10 No ChangeN/A4.3 $0.29Could this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. YBGJ Short Interest - Frequently Asked Questions What is Yubo International Biotech's current short interest? Short interest is the volume of Yubo International Biotech shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 100 shares of YBGJ short. Learn More on Yubo International Biotech's current short interest. Is Yubo International Biotech's short interest increasing or decreasing? Yubo International Biotech saw a drop in short interest in April. As of April 15th, there was short interest totaling 100 shares, a drop of 90.9% from the previous total of 1,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Yubo International Biotech's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Yubo International Biotech: Positron Co. (0.00%), Precision Optics Co., Inc. (0.16%), electroCore, Inc. (0.18%), Pixie Dust Technologies, Inc. (0.02%), BioSig Technologies, Inc. (10.35%), Movano Inc. (0.63%), Vaso Co. (0.01%), Hyperfine, Inc. (2.64%), Vivani Medical, Inc. (1.97%), FONAR Co. (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Yubo International Biotech stock? Short selling YBGJ is an investing strategy that aims to generate trading profit from Yubo International Biotech as its price is falling. YBGJ shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Yubo International Biotech? A short squeeze for Yubo International Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of YBGJ, which in turn drives the price of the stock up even further. How often is Yubo International Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including YBGJ, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: POSC Short Interest Data POCI Short Interest Data ECOR Short Interest Data PXDT Short Interest Data BSGM Short Interest Data MOVE Short Interest Data VASO Short Interest Data HYPR Short Interest Data VANI Short Interest Data FONR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:YBGJ) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings